No disproportionate reporting of inflammatory arthritis following COVID-19 vaccination: a pharmacovigilance study using VAERS data

Further Publications ImmunologyFurther Publications Rheumatology

Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study

Vaccines (Basel)

Calderaro DC, Valim V, Ferreira GA, Machado KLLL, Ribeiro PDC, Ribeiro SLE, Sartori NS, de Rezende RPV, de Melo AKG, Cruz VA, Vieira ASR, Kakehasi AM, de Landa AT, Burian APN, Peixoto FMMMC, Telles CMPF, do Espírito Santo RC, Baptista KL, de Oliveira YGP, Magalhães VO, de Lima RL, Biegelmeyer E, Lorencini PZ, Teixeira-Carvalho A, Dos Reis-Neto ET, Sato EI, Pinheiro MM, Monticielo OA, de Souza VA, Xavier RM, Pileggi GS, SAFER-Study Group Task Force

doi: 10.3390/vaccines12091031

Further Publications Immunology

Incidence of post-acute COVID-19 symptoms across healthcare settings in seven countries: an international retrospective cohort study using routinely-collected data

EClinicalMedicine

Xie J, López-Güell K, Dedman D, Duarte-Salles T, Kolde R, López-Blasco R, Martínez Á, Mercier G, Abellan A, Arinze JT, Cuccu Z, Delmestri A, Delseny D, Khalid S, Kim C, Kim JW, Kostka K, Loste C, Mateu L, Mayer MA, Meléndez-Cardiel J, Mercadé-Besora N, Mosseveld M, Nishimura A, Nordeng HME, Oyinlola JO, Pérez-Crespo L, Pineda-Moncusí M, Ramírez-Anguita JM, Trinh NTH, Uusküla A, Valdivieso B, Burkard T, Burn E, Català M, Prieto-Alhambra D, Paredes R, Jödicke AM

doi: 10.1016/j.eclinm.2024.102903

Further Publications Immunology

Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals' Public Assistance

Semin Arthritis Rheum

Gérard AL, Vieira M, Cohen A, Hassanaly O, Lambert J, Saadoun D

doi: 10.1016/j.semarthrit.2025.152660

Rheumatoid Arthritis

Avoidable Hospitalizations in Persons with Rheumatoid Arthritis: A Population-Based Study Using Administrative Data

Arthritis Care Res (Hoboken)

Contreras DG, Barber CEH, Aviña-Zubieta JA, Quan H, Lee S, King JA, Barnabe C

doi: 10.1002/acr.25541

Further Publications Immunology

A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial

Lancet Haematol

Cook JA, Patten PEM, Peckham N, Moss P, Phillips N, Abhishek A, Roberts T, Hodges M, Talbot G, Barber V, Francis A, Shields AM, Duley L, Hoogeboom R, Willett BJ, Scott S, Parry-Jones N, Eyre TA, Plested G, Vandici G, Wandroo FA, Hutchinson C, Paneesha S, Murray DJ, Martinez-Calle N, Jenkins S, Heartin E, Parry HM

doi: 10.1016/S2352-3026(25)00008-0

Rheumatoid Arthritis

Predictors of arthritis development in individuals at risk of rheumatoid arthritis: a 5-year follow-up study from a large cohort

Ann Rheum Dis

Frazzei G, Landewé RBM, Wagenaar C, van de Stadt LA, van Schaardenburg D, Tas SW, van Vollenhoven RF

doi: 10.1016/j.ard.2025.01.042

Rheumatoid Arthritis

Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational Study

Rheumatol Ther

Taylor PC, Fakhouri W, Ogwu S, Haladyj E, de la Torre I, Fautrel B, Alten R, Nash P, Feist E

doi: 10.1007/s40744-024-00732-8

Further Publications Immunology

Prevalence and demographics of 331 rare diseases and associated COVID-19-related mortality among 58 million individuals: a nationwide retrospective observational study

Lancet Digit Health

Thygesen JH, Zhang H, Issa H, Wu J, Hama T, Phiho-Gomes AC, Groza T, Khalid S, Lumbers TR, Hocaoglu M, Khunti K, Priedon R, Banerjee A, Pontikos N, Tomlinson C, Torralbo A, Taylor P, Sudlow C, Denaxas S, Hemingway H, Wu H, CVD-COVID-UK/COVID-IMPACT Consortium

doi: 10.1016/S2589-7500(24)00253-X

Rheumatoid Arthritis

Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study

Rheumatology (Oxford)

López-Medina C, Gorlier C, Orbai AM, Coates LC, Kiltz U, Leung YY, Palominos P, Cañete JD, Scrivo R, Balanescu A, Dernis E, Meisalu S, Ruyssen-Witrand A, Soubrier M, Aydin SZ, Eder L, Gaydukova I, Lubrano E, Kalyoncu U, Richette P, Husni ME, Smolen JS, de Wit M, Gossec L

doi: 10.1093/rheumatology/keaf002

Related content

Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study

Incidence of post-acute COVID-19 symptoms across healthcare settings in seven countries: an international retrospective cohort study using routinely-collected data

Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals' Public Assistance

Avoidable Hospitalizations in Persons with Rheumatoid Arthritis: A Population-Based Study Using Administrative Data

A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial

Predictors of arthritis development in individuals at risk of rheumatoid arthritis: a 5-year follow-up study from a large cohort

Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational Study

Prevalence and demographics of 331 rare diseases and associated COVID-19-related mortality among 58 million individuals: a nationwide retrospective observational study

Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study